Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis

BACKGROUND: Methylation of the tumor suppressor gene H-cadherin (CDH13) has been reported in many cancers. However, the clinical effect of the CDH13 methylation status of patients with bladder cancer remains to be clarified. METHODS: A systematic literature search was performed to identify eligible...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Feng, Huang, Tao, Ren, Yu, Wei, Junjun, Lou, Zhongguan, Wang, Xue, Fan, Xiaoxiao, Chen, Yirun, Weng, Guobin, Yao, Xuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004266/
https://www.ncbi.nlm.nih.gov/pubmed/27578166
http://dx.doi.org/10.1186/s12894-016-0171-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004266/
https://www.ncbi.nlm.nih.gov/pubmed/27578166
http://dx.doi.org/10.1186/s12894-016-0171-5

Ejemplares similares